• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vertex Pharmaceuticals (NQ: VRTX )

    477.90 +3.74 (+0.79%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 939,889
    Open 477.70
    Bid (Size) 472.46 (1)
    Ask (Size) 484.00 (2)
    Prev. Close 474.16
    Today's Range 476.27 - 483.98
    52wk Range 341.85 - 510.63
    Shares Outstanding 259,428,394
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
    Via Benzinga
    Looking Into Vertex Pharmaceuticals's Recent Short Interest
    Via Benzinga

    Performance

    YTD
    +16.30%
    +16.30%
    1 Month
    -2.08%
    -2.08%
    3 Month
    +1.38%
    +1.38%
    6 Month
    +15.96%
    +15.96%
    1 Year
    +33.39%
    +33.39%

    More News

    Read More
    Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
    Via The Motley Fool
    3 Stocks to Buy and Hold Forever
    Via The Motley Fool
    Prediction: These 3 Phenomenal Stocks Are Set to Soar
    Via The Motley Fool
    Time To Invest And Or Trade In Bio-Tech Stocks?
    Via Talk Markets
    Topics ETFs
    Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
    Via Benzinga
    Looking Into Vertex Pharmaceuticals's Recent Short Interest
    Via Benzinga
    Biotech Breakout: Stocks for Your Watchlist
    Via MarketBeat
    Topics ETFs
    Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
    Via Benzinga
    3 No-Brainer Stocks to Buy in September
    Via The Motley Fool
    3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
    Via The Motley Fool
    3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
    Via The Motley Fool
    Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
    Via Benzinga
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
    Via Benzinga
    Biotech And Life Science Sector Update Summer Of 2024
    Via Talk Markets
    Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
    Via Benzinga
    Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
    Via The Motley Fool
    Vertex to Participate in Upcoming September Investor Conferences
    From Vertex Pharmaceuticals Incorporated
    Via Business Wire
    Biotech Bull Market: 3 Ways To Play It
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
    Via Benzinga
    These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
    Via The Motley Fool
    3 Fantastic Growth Stocks to Buy in August
    Via The Motley Fool
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: August 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.